We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$1.67B
AUM Growth
+$135M
Cap. Flow
+$22.1M
Cap. Flow %
1.32%
Top 10 Hldgs %
32.92%
Holding
336
New
30
Increased
77
Reduced
81
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.9M
2
STI
SunTrust Banks, Inc.
STI
+$17M
3
APTV icon
Aptiv
APTV
+$15.8M
4
INTC icon
Intel
INTC
+$13.5M
5
CRM icon
Salesforce
CRM
+$12.6M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$27.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$24.2M
3
PANW icon
Palo Alto Networks
PANW
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$17.1M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Industrials 18.82%
2 Communication Services 14.56%
3 Healthcare 11.18%
4 Technology 10.25%
5 Consumer Discretionary 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLLI icon
76
Ollie's Bargain Outlet
OLLI
$4.31B
$1M 0.06%
30,000
BABA icon
77
Alibaba
BABA
$276B
$997K 0.06%
9,250
+2,500
+37% +$254K
SNY icon
78
Sanofi
SNY
$107B
$973K 0.06%
21,500
+1,500
+8% +$63.6K
NVDA icon
79
NVIDIA
NVDA
$4.6T
$969K 0.06%
356,000
+68,000
+24% +$181K
CNI icon
80
Canadian National Railway
CNI
$78.5B
$961K 0.06%
13,000
-89
-0.7% -$6.31K
AGN
81
DELISTED
Allergan plc
AGN
$956K 0.06%
4,000
+1,999
+100% +$466K
ZYNE
82
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$942K 0.06%
+46,850
New +$931K
BTI icon
83
British American Tobacco
BTI
$136B
$928K 0.06%
14,000
-92
-0.7% -$5.69K
SNN icon
84
Smith & Nephew
SNN
$13.7B
$928K 0.06%
30,000
-133
-0.4% -$4.07K
NOC icon
85
Northrop Grumman
NOC
$76B
$922K 0.06%
3,875
-1,250
-24% -$297K
AXP icon
86
American Express
AXP
$224B
$912K 0.05%
+11,525
New +$901K
BP icon
87
BP
BP
$112B
$909K 0.05%
30,210
-1,778
-6% -$54K
VOD icon
88
Vodafone
VOD
$37.1B
$897K 0.05%
33,954
+3,000
+10% +$76.8K
TTM
89
DELISTED
Tata Motors Limited
TTM
$891K 0.05%
25,000
VMC icon
90
Vulcan Materials
VMC
$36.8B
$873K 0.05%
7,245
-975
-12% -$119K
SCI icon
91
Service Corp International
SCI
$11.8B
$857K 0.05%
27,753
+17,250
+164% +$519K
LUX
92
DELISTED
Luxottica Group
LUX
$853K 0.05%
15,503
+7,500
+94% +$400K
TSLA icon
93
Tesla
TSLA
$1.18T
$835K 0.05%
45,000
+1,500
+3% +$25.4K
BUD icon
94
AB InBev
BUD
$164B
$826K 0.05%
7,525
+2,000
+36% +$215K
CNQ icon
95
Canadian Natural Resources
CNQ
$96.9B
$820K 0.05%
51,050
-2,042
-4% -$30.9K
ALV icon
96
Autoliv
ALV
$9.14B
$818K 0.05%
11,104
-22
-0.2% -$1.7K
RDY icon
97
Dr. Reddy's Laboratories
RDY
$9.8B
$803K 0.05%
100,000
EXP icon
98
Eagle Materials
EXP
$6.49B
$801K 0.05%
8,250
-13,266
-62% -$1.35M
SU icon
99
Suncor Energy
SU
$77.7B
$769K 0.05%
25,000
GLOG
100
DELISTED
GASLOG LTD
GLOG
$768K 0.05%
50,000
+10,000
+25% +$160K

Similar funds

R.H. Bluestein & Co's Q1 2017 Portfolio in Review

As of Q1 2017, R.H. Bluestein & Co held 336 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

R.H. Bluestein & Co's Q1 2017 filing shows 30 new, 77 increased, 81 reduced and 11 closed positions. Its largest new stake was SunTrust Banks, Inc.: 296,401 shares worth $16.4M. The largest sale was Monsanto Co, an estimated $27.3M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.

  • R.H. Bluestein & Co's largest Q1 2017 buy was SunTrust Banks, Inc.: 296,401 shares worth $16.4M.
  • R.H. Bluestein & Co added most to Microsoft in Q1 2017, an estimated $18.9M increase.
  • R.H. Bluestein & Co's biggest Q1 2017 reduction was Monsanto Co, cutting an estimated $27.3M.
  • R.H. Bluestein & Co fully exited Bristol-Myers Squibb in Q1 2017, selling an estimated $24.2M.
  • R.H. Bluestein & Co's ten largest holdings make up 33% of its $1.67B portfolio in Q1 2017.
  • R.H. Bluestein & Co opened 30 new positions and closed 11 in Q1 2017.
  • R.H. Bluestein & Co's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on R.H. Bluestein & Co's 13F filing for Q1 2017, filed 12 May 2017.